M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
University of Maryland, National Institute of Standards and Technology to Host First National Summit on Biosimilars; Speakers from FDA, NIST, Amgen, MedImmune, Teva to Discuss Policy, Company Strategies for Making Potentially Cheaper, Similar Therapeutics
COLLEGE PARK, Md. -- The University of Maryland and the National Institute for Standards and Technology (NIST) will host the first national symposium to discuss biosimilar therapeutics on June 13, 2014, at the Institute for Bioscience and Biotechnology Research in Rockville, Md., university...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives